NOV Q1 2026 Earnings EPS Misses Estimates Sharply as Revenue Details Remain Unreported Upstream Bio Inc UPB Q1 2026 Earnings Narrowed Loss Per Share as Clinical Pipeline Advances ODYS Q1 2026 Earnings EPS Miss Widens as PreRevenue Company Navigates Development Stage Cullinan Therapeutics Inc CGEM Q1 2026 Earnings Beat on EPS with NarrowerThanExpected Loss Airship AI Holdings Inc AISP Q3 2025 Earnings Significant EPS Miss Yet Stock Surges ADAMZ Q1 2026 Earnings Preferred Stock Delivers Strong EPS Beat Despite Modest Share Decline